Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.75USD
22 Mar 2019
Change (% chg)

$-0.43 (-5.26%)
Prev Close
$8.18
Open
$8.11
Day's High
$8.11
Day's Low
$7.75
Volume
216,849
Avg. Vol
48,904
52-wk High
$12.00
52-wk Low
$6.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.621
Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 5 0.30 1.50 0.00 --
Quarter Ending Jun-19 5 0.30 1.50 0.00 --
Year Ending Dec-19 5 1.28 6.40 0.00 1.54
Year Ending Dec-20 5 15.92 79.60 0.00 11.72
Earnings (per share)
Quarter Ending Mar-19 5 -0.52 -0.41 -0.58 -0.97
Quarter Ending Jun-19 5 -0.47 -0.42 -0.61 -0.97
Year Ending Dec-19 5 -1.97 -1.70 -2.53 -2.34
Year Ending Dec-20 5 -1.88 -1.33 -2.21 -1.97
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.73 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) 18.07 49.53 8.39
Price to Book (MRQ) 1.40 10.19 5.27
Price to Tangible Book (MRQ) 1.40 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 64.29 3.73 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.72 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -0.67 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -1.90 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago -20.52 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 14.98 3.50 2.98
LT Debt to Equity (MRQ) 0.00 19.47 11.35
Total Debt to Equity (MRQ) 0.00 32.15 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -508.77 -- --
EBITD - 5 Yr. Avg -- -110.45 12.43
Operating Margin (TTM) -512.56 -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.93 8.02
Pre-Tax Margin (TTM) -506.49 -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.72 8.31
Net Profit Margin (TTM) -506.49 -182.45 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.11 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.51 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 161,900 7,655,763 820,308,580
Net Income/Employee (TTM) -820,000 513,903 92,854,694
Receivable Turnover (TTM) 3.42 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.07 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.06 6.37 10.60
Return on Assets - 5 Yr. Avg. -- 5.46 11.78
Return on Investment (TTM) -36.00 8.89 13.82
Return on Investment - 5 Yr. Avg. -- 6.77 15.32
Return on Equity (TTM) -36.04 10.02 15.24
Return on Equity - 5 Yr. Avg. -- 8.30 16.41
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.07 19.79 84 99
13 Week 57.37 49.71 91 95
26 Week -26.41 -32.01 25 98
52 Week -23.68 -35.31 35 71
YTD 22.64 7.71 61 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.80%
# of Holders: 97
Total Shares Held: 19,252,062
3 Mo. Net Change: 1,731,579
# New Positions: 14
# Closed Positions: 16
# Increased Positions: 42
# Reduced Positions: 38
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.